Prophylactic transanal irrigation for low anterior resection syndrome following rectal resection Study protocol of a randomized controlled multicenter trial

Background
During the past few decades, modern colorectal surgery has aimed to achieve preservation of the anal sphincter after low (or "ultralow") anterior rectal resection down to a level of 1-2 cm above the dentate line. Our understanding of the local spread in rectal cancer as well as the effect of neoadjuvant chemo/ radiotherapy has justified the use of ultralow or coloanal anastomoses as well as intersphincteric resections from the oncologic point of view. However, the effect of such strategies on functional outcome of the new "continence organ" has been hotly debated.
Todayitiswidelyacceptedthatsphincter preservation in this setting leads to deterioration of anal continence compared with the preoperative status and frequently to a functional change that may cause major problems [1, 2] .
Low anterior resection syndrome (LARS) has been described by in the literature as a disorder consisting of frequent (unproductive) bowel movements, repeated fecal urgency followed by fragmentation of the bowel content ("clustering"), emptying difficulties, and-finally-anal incontinence of various degrees of severity [1] [2] [3] .
More recently, LARS and its major negative impact on quality of life (QoL) have gained increasing attention in the medical literature. Today, it is widely accepted that some or all of the aforementioned functional problems will be experienced by up to 80% of all patients after anterior rectal resection.
Although it was the general opinion that most of these functional impairments will significantly improve within 6-12 months, more recently published long-term data show persistence of LARS in about 50% of patients even up to more than 10 years after their primary surgery [4, 5] .
Loss of the reservoir function of the removed rectal ampulla and changes in the colonic motility following mobilization of the left hemicolon have been associated with most of the observed functional changes [1, 6] . Low rectal volume and low maximal rectal capacity as well as deteriorated anal sphincter function have been considered the major mechanisms leading to LARS and are additionally negatively influenced by neoadjuvant radiotherapy [4] .
Although various surgical attempts have been made to approach this problem by formation of a neo-reservoir (Jpouch, coloplasty, Baker anastomosis), it is accepted that this does not lead to a complete resolution of all LARSassociated problems [7] . Even after successful construction of a "neoreservoir" by means of a colonic J-pouch, up to six defecation episodes per day have been observed after more than 12 months' follow-up. Furthermore, it should be noted that in a certain number of patients only a straight coloanal anastomosis will be technically feasible owing to anatomic limitations [7] .
In addition to this, more recent research of colorectal physiology has revealed that removal of the sigmoid and rectum has a major impact on colonic motility leading to an elimination of the so-called rectal motor complex, which is regarded as a mechanism that is able to slow down ("brake") the transport of bowel content [8] .
Owing to the significant negative impact of LARS on QoL, increasing attention has been placed on the management of this problem. Although a more structured classification of the degree of this disorder by a validated scoring system has been achieved [9] , successful treatment has been limited to date.
Dietary approaches including a fiberrich diet and constipating agents as well as pelvic floor muscle training are still regarded as the first-line therapyalthough scientific evidence of their effect in LARS is lacking and their efficacy in this special subset of patients must be questioned [10, 11] .
The introduction of sacral nerve stimulation (SNS) as an effective treatment for functional pelvic floor problems has led to its application in some patients with LARS. Although the success of this therapy has been described in single-center publications and case reports, the high price of the device and the lack of scientific evidence prevent it from being recommended for wider use in patients with LARS [12] .
Transanal irrigation (TAI) was described as an effective approach for functional problems following rectal resection as early as 1989 [13] ; however, TAI failed to get broader attention in the surgical community and it was only until the new millennium that different European study groups "reinvented" this treatment for severe LARS in the followup of patients after rectal resection [10, 11, 14] .
These publications show nicely that a regular wash-out of the colon will lead to a marked reduction in defecation episodes, as well as the possibility of a controlled, voluntary rectal emptying of the "neorectum" by the patient, thus leading to an improved QoL and "normalization" of the patient's social and professional life.
Taking into account that LARS will affect the majority of patients after rectal resection and almost everyone after "ultralow" rectal resection, including coloanal anastomosis, our study group decided to evaluate the effect of a prophylactic application in patients before closure of their protective ostomy following LARS. 
Abstract · Zusammenfassung
Primary endpoint
The primary endpoint is reduction in defecation episodes both diurnal and nocturnal by TAI every 24 h following closure of the protective stoma.
Secondary endpoints
Secondary endpoints include evaluation of the effect of TAI on QoL by use of the LARS score [9] as well as the SF-36 questionnaire at 1 week, 1 month, and 3 months following stoma closure. Following this, further management of the patients is decided by each participating center, e. g., introduction of TAI for patients primarily randomized to the control arm, termination of TAI or reduction of the irrigation volume for patients in the "TAI group". However, the patients' number of defecation episodes, LARS score, and SF-36 results will be documented during the individual follow-up.
Transanal irrigation
Following fulfilment of the inclusion criteria, patients will be randomly allocated either to a TAI or a control group that will receive best conservative (supportive) therapy. Presence or absence of a colonic pouch will be used as a stratification criterion during the randomization process.
Patients randomized to the TAI group will be instructed by a dedicated (stoma) therapist/nurse on how to use the irrigation system before they undergo stoma closure. This should guarantee that patients will already have sufficient experience in using TAI when their bowel function starts after stoma closure.
After the beginning of bowel movement, TAI will be started using 1000 ml of tap water every 24 h at a time point that can be chosen individually by the patients.
Based on previously reported experiences [10] , TAI will be performed with the Peristeen ® system (Coloplast A/S, Humblebaek, Denmark); however, in patients with difficulties in introducing the irrigator due to stenosis of the anastomosis, application of a large (28 French) Foley catheter will be accepted, which can be flushed by using 100-ml syringes.
Statistical analysis
Sample size
In a joint Austrian-Swiss study the authors were able to reduce the median number of defecation episodes in patients suffering from LARS from a median number of eight episodes per day to one per day, as well as from three per night to no episodes by application of TAI every 24 h.
Based on these observations and calculating a minimal power of 0.80 and a significance level of 0.05 in a two-sided hypothesis, a sample size of 15 patients per group was regarded as the acceptable sample size for this trial.
Summary
Defecation disorders and incontinence are common following low anterior resection of the rectum, and transanal irrigation (TAI) has been reported to be a cheap and effective treatment to improve QoL of patients suffering from LARS. Based on these observations as well as on the fact that the majority of all patients following anterior resection will be affected significantly in the immediate period following closure of their protective ostomies, a prophylactic application of TAI to prevent deterioration of QoL was discussed. Therefore, a multicenter randomized controlled trial was planned to evaluate the effect of TAI on the number of defecation episodes, LARS score, and SF-36 questionnaire results compared with a control group who will receive the conventional supportive management following anterior resection.
